ArticleInternational journal of molecular sciences2021

NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.

Cheng-Yu Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.